Navigation Links
Ranexa(R) Significantly Reduces Ischemia in Women in MERLIN TIMI-36 Study
Date:11/6/2007

ORLANDO, Fla., Nov. 6 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) announced today that an analysis of data from 2,291 women who participated in the MERLIN TIMI-36 study showed a 29 percent reduction in the relative risk of recurrent ischemia in women receiving Ranexa(R) (ranolazine extended-release tablets) compared to placebo (p=0.002) after 12 months. No difference in symptomatic documented arrhythmias was observed in women between the ranolazine and placebo groups.

The data were presented today by Dr. Jessica Mega of the TIMI Study Group at the American Heart Association Scientific Sessions in Orlando, Florida.

"Women were very well represented in the MERLIN TIMI-36 study and these data provide important additional confirmation of the safety and efficacy we have seen with Ranexa in other clinical trials and in commercial use," said Louis G. Lange, CV Therapeutics chairman and chief executive officer.

According to the American Heart Association, cardiovascular disease is the leading cause of death among American women.

In accordance with a special protocol assessment agreement between the U.S. Food and Drug Administration (FDA) and CV Therapeutics, the Company believes that data from the MERLIN TIMI-36 study could support expansion of the existing Ranexa indication to first line angina. In September 2007, the Company submitted a supplemental new drug application to the FDA seeking a new indication for first line angina and a significant reduction in cautionary language.

Ranexa is currently indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and should be used in combination with amlodipine,
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP
2. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
3. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
4. Study shows adverse drug events reported to the FDA have significantly increased
5. Rehabilitation significantly underused after heart attack and bypass surgery
6. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
7. National Domestic Violence Hotline Unveils 10-Year Blueprint to Significantly Reduce Domestic Violence in America
8. New Study Shows Arthritis Significantly Limits Millions of Americans Ability to Work
9. World Bank Group Report on Malaria in Africa Highlights Progress Towards Goal of Significantly Reducing Malaria Deaths
10. Psychiatrists, parents significantly differ in ADHD, psychiatric comorbidities perceptions
11. Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 26, 2014 The past five ... Sugar Cane Growing industry in Australia . ... by extreme weather patterns, volatile commodity prices and ... industry analyst Brooke Tonkin, “Over the period, flooding ... of Australia's sugar cane crop.” Consequently, industry revenue ...
(Date:10/25/2014)... 25, 2014 Triton Algae Innovations, ... announced Dr. Xun Wang has joined the ... Development. , Triton has developed a patented synthetic biology ... According to Dr. Wang, the platform uses algae to ... He says, “Algae are unique because they can produce ...
(Date:10/25/2014)... 26, 2014 BioSkinLaser.Com, the leading and ... advanced and improved laser treatments for its customers. BioSkinLaser ... like the lip enhancement treatment . It offers ... focus areas of each customer. , BioSkinLaser.Com has also ... NYC . The company cited that it created the ...
(Date:10/25/2014)... The proposed consolidation of all federally-filed ... December, when the U.S. Judicial Panel on Multidistrict Litigation ... Hearing Session Order issued by the Panel on October ... on December 4, 2014, in Charleston, South Carolina. The ... Xarelto Products Liability Litigation, No. 2592) , “Our Firm ...
(Date:10/25/2014)... The global HCIT outsourcing market is forecast to ... billion by 2018 from $35 billion in 2013. The ... are driving the HCIT outsourcing market. These industries follow ... core business, reduce operational and maintenance costs, increase access ... and training costs), share risk, and quickly implement new ...
Breaking Medicine News(10 mins):Health News:Sugar Cane Growing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Cane Growing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 3Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 2Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 3Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 2Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 4
... in some way. For some people, the most convenient ... in exercise machines to help burn calories and increase ... preferences, budget and health, some aerobic exercise machines may ... of Mayo Clinic Health Letter covers some options: ...
... a clear indication in a scientific journal regarding a ... the drug was tested on human participants, which turned ... timely emergency care services, the participants would have been ... reasons for the mishap of the trial, blamed gross ...
... of Newcastle disease on an East Lothian farm has led to ... // is usually fatal for birds and a 3km protection zone ... Fenton Barns, Drem, to prevent its spread. ,According to ... not linked to bird flu. However it can spread rapidly in ...
... the funds that was provided by the US administration ... to men in Swaziland. ,According to the U.S. ... of the program and that it violated government policy ... procedure. ,Over the past 12 months around 300 ...
... surgery was made at a major conference on brain tumours ... , ,According to the Irish Cancer Society, in spite ... higher rate of success and any damge to the delicate ... that there were 316 new cases of primary brain tumour ...
... advanced nations of the world today, Britain had to face ... in Europe' last week. //In a recent report by CABE ... of the nation's population can be declared obese and overweight. ... (CABE) with its headquarters in London works towards improving people's ...
Cached Medicine News:Health News:Home Is Where the Gym Is 2Health News:Bush Administration Proposes End of Funding of Anti-AIDS Program in Swaziland 2Health News:Awake Surgery to treat Brain tumours 2
(Date:10/22/2014)...   BioNano Genomics , the genome mapping ... to purchase an Irys™ System . Among them ... (NCI), NIH Intramural Sequencing Center (NISC) and Genoscope (The ... comprehensive view of a genome was a major ... deliver the scalability or reliability to detect and ...
(Date:10/22/2014)... Oct. 21, 2014 Influenza will affect as many ... the United States as high as ... to spread is from person to person in respiratory droplets ... serve way of death, but kills much fewer people each ... done by human fluids including sweat, saliva, blood and other ...
(Date:10/22/2014)... 2014 Sanomedics International Holdings, Inc. (OTCQB: SIMH) ... Research & Data Services, demand for thermometers is expected ... 2018, as demand for more accurate digital thermometers continues.  ... world,s largest market for thermometers, and one of the ... International Holdings, Inc. Sanomedics International Holdings designs, ...
Breaking Medicine Technology:BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: